683 Capital Management, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH)

Filing Manager
683 Capital Management, LLC
Reporting Manager
683 CAPITAL MANAGEMENT, LLC
Security
REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share
Symbol
RVPH
Shares outstanding
116,416,667 shares
Disclosed Ownership
3,492,500 shares
Ownership
3%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:19:20 UTC
Date of event
31 Dec 2025
Previous filing
29 Sep 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"683 Capital Management, LLC disclosed 3% ownership in REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH) on 31 Dec 2025."

Quick Takeaways

  • 683 Capital Management, LLC filed SCHEDULE 13G/A for REVIVA PHARMACEUTICALS HOLDINGS, INC. Common Stock, par value $0.0001 per share (RVPH).
  • Disclosed ownership: 3%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 29 Sep 2025.
  • Current filing was accepted on 17 Feb 2026, 16:19.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
683 CAPITAL MANAGEMENT, LLC 3% 3,492,500 0 3,492,500 /s/ Ari Zweiman Ari Zweiman, Managing Member
683 CAPITAL PARTNERS, LP 3% 3,492,500 0 3,492,500 /s/ Ari Zweiman Ari Zweiman, Authorized Person
Zweiman Ari 3% 3,492,500 0 3,492,500 /s/ Ari Zweiman Ari Zweiman, Self

Sponsored